NCT07544654 2026-04-22
A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
Boehringer Ingelheim
Phase 3 Not yet recruiting
Boehringer Ingelheim
National Institute of Cardiology, Warsaw, Poland
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
First Affiliated Hospital of Zhejiang University
GCS Ramsay Santé pour l'Enseignement et la Recherche
Hospices Civils de Lyon
Xijing Hospital